Bank of America’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-144,200
Closed -$7.89M 7675
2025
Q3
$7.89M Hold
144,200
﹤0.01% 3545
2025
Q2
$7.66M Sell
144,200
-27,100
-16% -$1.38M ﹤0.01% 3467
2025
Q1
$7.42M Buy
171,300
+43,500
+34% +$2.2M ﹤0.01% 3440
2024
Q4
$7.18M Buy
+127,800
New +$7.95M ﹤0.01% 3242
2024
Q3
Sell
-18,500
Closed -$782K 8231
2024
Q2
$782K Sell
18,500
-11,500
-38% -$633K ﹤0.01% 5055
2024
Q1
$2.07M Buy
+30,000
New +$1.9M ﹤0.01% 4429
2023
Q3
Sell
-800
Closed -$75.1K 7818
2023
Q2
$75.1K Buy
+800
New +$62.4K ﹤0.01% 6314
2023
Q1
Sell
-28,400
Closed -$1.41M 7935
2022
Q4
$1.41M Buy
+28,400
New +$1.16M ﹤0.01% 4571
2022
Q3
Sell
-1,400
Closed -$55K 7946
2022
Q2
$55K Buy
+1,400
New +$74.9K ﹤0.01% 6786
2021
Q3
Sell
-142,900
Closed -$17.8M 8183
2021
Q2
$17.8M Buy
142,900
+79,100
+124% +$9.44M ﹤0.01% 2252
2021
Q1
$8.41M Buy
63,800
+27,800
+77% +$3.81M ﹤0.01% 2892
2020
Q4
$4.77M Hold
36,000
﹤0.01% 3174
2020
Q3
$3.67M Hold
36,000
﹤0.01% 3192
2020
Q2
$3.13M Hold
36,000
﹤0.01% 3271
2020
Q1
$2.09M Sell
36,000
-40,900
-53% -$3.32M ﹤0.01% 3446
2019
Q4
$7.11M Sell
76,900
-172,300
-69% -$15.1M ﹤0.01% 2889
2019
Q3
$22.5M Buy
249,200
+177,400
+247% +$20.2M ﹤0.01% 1736
2019
Q2
$8.47M Buy
71,800
+35,400
+97% +$3.57M ﹤0.01% 2722
2019
Q1
$3.15M Sell
36,400
-182,600
-83% -$15.5M ﹤0.01% 3607
2018
Q4
$13.8M Sell
219,000
-15,200
-6% -$1.04M ﹤0.01% 1995
2018
Q3
$18.5M Buy
234,200
+111,000
+90% +$7.24M ﹤0.01% 1898
2018
Q2
$7.37M Sell
123,200
-5,300
-4% -$285K ﹤0.01% 2760
2018
Q1
$5.18M Sell
128,500
-266,000
-67% -$13M ﹤0.01% 3048
2017
Q4
$20.7M Buy
394,500
+368,900
+1,441% +$19.7M ﹤0.01% 1765
2017
Q3
$1.21M Hold
25,600
﹤0.01% 4379
2017
Q2
$905K Sell
25,600
-21,400
-46% -$661K ﹤0.01% 4499
2017
Q1
$1.11M Sell
47,000
-4,700
-9% -$93.1K ﹤0.01% 4363
2016
Q4
$691K Buy
51,700
+23,000
+80% +$371K ﹤0.01% 4603
2016
Q3
$533K Buy
28,700
+22,000
+328% +$388K ﹤0.01% 4572
2016
Q2
$82K Buy
+6,700
New +$50.5K ﹤0.01% 5621
2016
Q1
Sell
-3,000
Closed -$28K 7090
2015
Q4
$28K Hold
3,000
﹤0.01% 6290
2015
Q3
$54K Sell
3,000
-125,600
-98% -$2.89M ﹤0.01% 5928
2015
Q2
$3.83M Buy
128,600
+125,600
+4,187% +$3.16M ﹤0.01% 2829
2015
Q1
$66K Sell
3,000
-201,000
-99% -$5.1M ﹤0.01% 5524
2014
Q4
$5.6M Buy
204,000
+193,200
+1,789% +$4.7M ﹤0.01% 2458
2014
Q3
$209K Buy
10,800
+6,700
+163% +$123K ﹤0.01% 5350
2014
Q2
$70K Sell
4,100
-10,300
-72% -$142K ﹤0.01% 6397
2014
Q1
$204K Sell
14,400
-34,200
-70% -$462K ﹤0.01% 5421
2013
Q4
$571K Sell
48,600
-500
-1% -$5.74K ﹤0.01% 4645
2013
Q3
$579K Buy
49,100
+48,300
+6,038% +$620K ﹤0.01% 4484
2013
Q2
$11K Buy
+800
New +$8.69K ﹤0.01% 7142

Other funds holding EXAS

Bank of America's EXAS Position: Q1 2026 in Review

Bank of America sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 844,226 shares — an estimated $85.7M sold.

Bank of America first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $158M in Q1 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Bank of America reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 844,226 Exact Sciences shares in Q1 2026, an estimated $85.7M.
  • Bank of America first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • Bank of America's Exact Sciences position peaked at $158M in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.